142 related articles for article (PubMed ID: 19479678)
1. Fetal nuchal translucency thickness evaluation in the overweight and obese gravida.
Thornburg LL; Mulconry M; Post A; Carpenter A; Grace D; Pressman EK
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):665-9. PubMed ID: 19479678
[TBL] [Abstract][Full Text] [Related]
2. Fetal anatomic evaluation in the overweight and obese gravida.
Thornburg LL; Miles K; Ho M; Pressman EK
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):670-5. PubMed ID: 19479682
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound screening for fetal aneuploidy using soft markers in the overweight and obese gravida.
Tsai LJ; Ho M; Pressman EK; Thornburg LL
Prenat Diagn; 2010 Sep; 30(9):821-6. PubMed ID: 20575150
[TBL] [Abstract][Full Text] [Related]
4. The relationship between maternal body mass, smoking status and ethnicity and first trimester nuchal translucency thickness.
Cowans NJ; Spencer K
Prenat Diagn; 2011 May; 31(5):446-9. PubMed ID: 21351280
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
6. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
7. Effect of increased body mass index on first-trimester ultrasound examination for aneuploidy risk assessment.
Gandhi M; Fox NS; Russo-Stieglitz K; Hanley ME; Matthews G; Rebarber A
Obstet Gynecol; 2009 Oct; 114(4):856-859. PubMed ID: 19888045
[TBL] [Abstract][Full Text] [Related]
8. Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardization.
Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; de Jonge ET; Ombelet WU; Nijhuis JG
Ultrasound Obstet Gynecol; 2004 Oct; 24(5):511-5. PubMed ID: 15459938
[TBL] [Abstract][Full Text] [Related]
9. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness.
Vandecruys H; Faiola S; Auer M; Sebire N; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):551-3. PubMed ID: 15880648
[TBL] [Abstract][Full Text] [Related]
10. The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, 2004-2011.
Scott-Pillai R; Spence D; Cardwell CR; Hunter A; Holmes VA
BJOG; 2013 Jul; 120(8):932-9. PubMed ID: 23530609
[TBL] [Abstract][Full Text] [Related]
11. First-trimester nuchal translucency screening in pregnant women who subsequently developed gestational diabetes.
Leipold H; Worda C; Ozbal A; Husslein P; Krampl E
J Soc Gynecol Investig; 2005 Oct; 12(7):529-32. PubMed ID: 16046155
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
[TBL] [Abstract][Full Text] [Related]
13. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
Spencer K; Cicero S; Atzei A; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):927-9. PubMed ID: 16088864
[TBL] [Abstract][Full Text] [Related]
14. Associations of gestational weight loss with birth-related outcome: a retrospective cohort study.
Beyerlein A; Schiessl B; Lack N; von Kries R
BJOG; 2011 Jan; 118(1):55-61. PubMed ID: 21054761
[TBL] [Abstract][Full Text] [Related]
15. Fetal echocardiography at the time of the nuchal translucency scan.
Lombardi CM; Bellotti M; Fesslova V; Cappellini A
Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
[TBL] [Abstract][Full Text] [Related]
16. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
17. Impact of maternal obesity and maternal overweight on the detection rate of fetal heart defects and the image quality of prenatal echocardiography.
Uhden M; Knippel AJ; Stressig R; Hammer R; Siegmann H; Froehlich S; Kozlowski P
Ultraschall Med; 2011 Dec; 32 Suppl 2():E108-14. PubMed ID: 21877317
[TBL] [Abstract][Full Text] [Related]
18. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
19. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
20. Miscarriage after a normal scan at 12-14 gestational weeks in women at low risk of carrying a fetus with chromosomal anomaly according to nuchal translucency screening.
Westin M; Källén K; Saltvedt S; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2007 Oct; 30(5):728-36. PubMed ID: 17823976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
